Insulin resistance improving agents

Details Insulin resistance improving agents Insulin resistance improving agents

A - Human Necessities

61

K

A61K 31/4245 (2006.01) A61P 3/10 (2006.01) A61P 5/50 (2006.01) A61P 9/12 (2006.01) C07D 413/10 (2006.01)

Patent

CA 2468827

Drugs having a high safety and exerting excellent effects of, for example, improving insulin resistance on a large number of patients suffering from diseases in association with insulin resistance such as diabetes. Namely, insulin resistance improving agents, sugar tolerance failure relieving agents, preventives/remedies for diabetes and hyperinsulinemia, etc. which contain 2- ethoxy-1-[[2~-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylic acid or its salt.

La présente invention concerne des produits pharmaceutiques ayant une fiabilité élevée et d'excellents effets, par exemple pour améliorer l'état de résistance à l'insuline chez un grand nombre de patients souffrant de troubles associés à la résistance à l'insuline tels que le diabète. Lesdits produits pharmaceutiques sont des agents pour améliorer l'état de résistance à l'insuline, des agents pour éliminer les problèmes d'intolérance au sucre, des agents pour prévenir/traiter le diabète et l'hyperinsulinémie, etc., qui contiennent de l'acide 2-éthoxy-1-[[2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)biphényl-4-yl]méthyl]-1H-benzimidazole-7-carboxylique ou son sel.

Affiliated with

Also associated with

Rating

Insulin resistance improving agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Insulin resistance improving agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin resistance improving agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1774474